PHIO Q2 2017 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$1M

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-6677.08

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$119,000

Balance Sheet

Total Assets

$8M

Total Liabilities

$2M

Stockholders' Equity

$6M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$9,000	-100.0%
Gross Profit	-$1M	-$1M	+0.1%
Operating Income	-$3M	-$2M	-13.5%
Net Income	-$3M	-$2M	-13.7%